Aldeyra Therapeutics, Inc. (ALDX) › Shareholders' EquityAldeyra Therapeutics, Inc. (ALDX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$54.38M2013: -$40.22M2014: $6.28M2015: $24.88M2016: $21.65M2017: $39.60M2018: $86.62M2019: $48.08M2020: $59.51M2021: $205.74M2022: $151.01M2023: $119.80M2024: $71.00M2025: $44.25M$44.25M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$44.25M-37.7%2024$71.00M-40.7%2023$119.80M-20.7%2022$151.01M-26.6%2021$205.74M+245.7%2020$59.51M+23.8%2019$48.08M-44.5%2018$86.62M+118.7%2017$39.60M+82.9%2016$21.65M-13.0%2015$24.88M+295.9%2014$6.28M+115.6%2013-$40.22M+26.0%2012-$54.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share